Montserrat Pérez-Salvia1, Eneko Aldaba2, Yosu Vara2, Myriam Fabre3, Cristina Ferrer3, Carme Masdeu4, Aizpea Zubia5, Eider San Sebastian5, Dorleta Otaegui6, Pere Llinàs-Arias1, Margalida Rosselló-Tortella1, Maria Berdasco1, Catia Moutinho1, Fernando Setien1, Alberto Villanueva7, Eva González-Barca8, Josep Muncunill9, José-Tomás Navarro9, Miguel A Piris10, Fernando P Cossio5, Manel Esteller11,12,13,14. 1. Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet, Barcelona, Catalonia. 2. Quimatryx, San Sebastian. 3. Oncomatryx, Arteaga Auzoa, 43, Derio. 4. Department of Organic Chemistry I, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), San Sebastián. 5. Department of Organic Chemistry I, Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), San Sebastián. 6. Mass Spectrometry Platform, CIC biomaGUNE, San Sebastian. 7. Laboratory of Translational Research, Catalan Institute of Oncology (ICO), IDIBELL L'Hospitalet, Barcelona, Catalonia. 8. Department of Hematology, ICO-Hospital Duran i Reynals, IDIBELL, University of Barcelona, L'Hospitalet, Barcelona, Catalonia. 9. Department of Hematology, ICO-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia. 10. Pathology Service, Fundación Jiménez Díaz, Madrid. 11. Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet, Barcelona, Catalonia mesteller@idibell.cat. 12. Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid. 13. Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), L'Hospitalet, Catalonia. 14. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
Authors: Stephen E Spurgeon; Brian G Till; Peter Martin; Andre H Goy; Martin P Dreyling; Ajay K Gopal; Michael LeBlanc; John P Leonard; Jonathan W Friedberg; Lawrence Baizer; Richard F Little; Brad S Kahl; Mitchell R Smith Journal: J Natl Cancer Inst Date: 2016-12-31 Impact factor: 13.506
Authors: Orion M Howard; John G Gribben; Donna S Neuberg; Michael Grossbard; Christina Poor; Milos J Janicek; Margaret A Shipp Journal: J Clin Oncol Date: 2002-03-01 Impact factor: 44.544
Authors: Tint Lwin; Xiaohong Zhao; Fengdong Cheng; Xinwei Zhang; Andy Huang; Bijal Shah; Yizhuo Zhang; Lynn C Moscinski; Yong Sung Choi; Alan P Kozikowski; James E Bradner; William S Dalton; Eduardo Sotomayor; Jianguo Tao Journal: J Clin Invest Date: 2013-11 Impact factor: 14.808
Authors: Montserrat Pérez-Salvia; Laia Simó-Riudalbas; Pere Llinàs-Arias; Laura Roa; Fernando Setien; Marta Soler; Manuel Castro de Moura; James E Bradner; Eva Gonzalez-Suarez; Catia Moutinho; Manel Esteller Journal: Oncotarget Date: 2017-05-29
Authors: Jaione Auzmendi-Iriarte; Ander Saenz-Antoñanzas; Idoia Mikelez-Alonso; Estefania Carrasco-Garcia; Maitena Tellaetxe-Abete; Charles H Lawrie; Nicolás Sampron; Aitziber L Cortajarena; Ander Matheu Journal: Cell Death Dis Date: 2020-06-02 Impact factor: 8.469